| Monthly Suspected and Confirmed Fatal Drug Overdoses in Maine | Overdose | Infrastructure | 4 | Monthly | January 2024 | 51 | 51 |
| Annual Suspected and Confirmed Fatal Drug Overdoses in Maine | Overdose | Infrastructure | 4 | Annually | 2023 | 608 | 608 |
| Quarterly Drug Overdoses in Maine Involving Fentanyl | Overdose | Infrastructure | 4 | Quarterly | Q4 2022 | 161 | 560 (2022) |
| Quarterly Drug Overdoses in Maine Involving Pharmaceutical Opioids | Overdose | Infrastructure | 4 | Quarterly | Q2 2022 | 45 | 156 (2022) |
| Quarterly Drug Overdoses in Maine Involving Heroin | Overdose | Infrastructure | 4 | Quarterly | Q2 2022 | 7 | 19 (2022) |
| Total Annual Lost Productivity Due to Drug-related Morbidity | Economic Impact | Infrastructure | 4.d. | Annually | 2018-2019 | $414,943,631 | $414,943,631 |
| Annual Lost Market Productivity Due to Drug-related Morbidity | Economic Impact | Infrastructure | 4.d. | Annually | 2018-2020 | $144,357,196 | $144,357,196 |
| Annual Lost Non-Market Productivity Due to Drug-related Morbidity | Economic Impact | Infrastructure | 4.d. | Annually | 2018-2021 | $270,586,435 | $270,586,435 |
| Lifetime Lost Productivity Due to Drug-related Mortality in Females | Economic Impact | Infrastructure | 4.d. | Annually | 2020 | $170,082,464 | $170,082,464 |
| Lifetime Lost Productivity Due to Drug-related Mortality in Males | Economic Impact | Infrastructure | 4.d. | Annually | 2020 | $564,150,431 | $564,150,431 |
| Overall Lifetime Lost Productivity Due to Drug-related Mortality | Economic Impact | Infrastructure | 4.d. | Annually | 2020 | $734,232,894 | $734,232,894 |
| Monthly Website Hits on the Maine Drug Data Hub | Data Impact | Infrastructure | 4.e. | Monthly | February 2024 | 78,245 | 165,633 |
| Monthly Visitors on the Maine Drug Data Hub | Data Impact | Infrastructure | 4.e. | Monthly | February 2024 | 3,559 | 6,412 |
| OD MAP Entries Made within 24 hours | Timeliness | Infrastructure | 4.g. | Monthly | August 2024 | 58% | 48% |
| Total Monthly Drug Arrests in Maine | Interdiction | Infrastructure | 4.h. | Monthly | March 2023 | 1,182 | 3,071 |
| Monthly Drug Arrests in Maine for Pharmaceutical Opioids | Interdiction | Infrastructure | 4.h. | Monthly | March 2023 | 8 | 16 |
| Monthly Drug Arrests in Maine for Methamphetamine | Interdiction | Infrastructure | 4.h. | Monthly | March 2023 | 114 | 301 |
| Monthly Drug Arrests in Maine for Fentanyl | Interdiction | Infrastructure | 4.h. | Monthly | March 2023 | 35 | 75 |
| Monthly Drug Arrests in Maine for Heroin | Interdiction | Infrastructure | 4.h. | Monthly | March 2023 | 114 | 321 |
| Monthly Drug Arrests in Maine for Cocaine | Interdiction | Infrastructure | 4.h. | Monthly | March 2023 | 42 | 125 |
| Quarterly Morphine Milligram Equivalents Prescribed | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 109,715,451 | 109,715,451 |
| Quarterly Patients Prescribed Opioids | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 63,358 | 63,358 |
| Quarterly Opioid Prescriptions | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 150,481 | 150,481 |
| Opiate Medication Prescriptions Issued Electronically vs. Non-electronically | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Annually | 2021 | 571,212 vs. 42,157 | 571,212 vs. 42,157 |
| Quarterly Benzodiazepine Prescriptions | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 111,423 | 111,423 |
| Quarterly Patients Prescribed Benzodiazepines | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 54,418 | 54,418 |
| Quarterly Stimulant Prescriptions | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 107,484 | 107,484 |
| Quarterly Patients Prescribed Stimulants | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q1 2023 | 43,574 | 43,574 |
| PMP Clinical Alerts for Patients with Over 100 MMEs | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q4 2021 | 21,418 | 69,164 |
| PMP Clinical Alerts for Patients with Concurrent Opioid and Benzodiazepine Rx | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q4 2021 | 52,564 | 191,053 |
| PMP Clinical Alerts for Patients with 5 or more Controlled Rx with Different Providers, at 5 or more Pharmacies, within 30 days (5x5x30) | Prescribing | Public Safety | 13.a, 13.b.; 13.c | Quarterly | Q4 2021 | 0 | 0 |
| Total Pounds of Drugs Collected at DEA Rx Takeback Day | Interdiction | Public Safety | 13.d. | Bi-Annually | April 2023 | 6,369 | 6,369 |
| Grams of Heroin Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 36 | 36 |
| Grams of Fentanyl Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 16,532 | 16,532 |
| Grams of Cocaine Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 3,181 | 3,181 |
| Grams of Methamphetamine Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 54,527 | 54,527 |
| Pharmaceutical Dosage Units Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 918 | 918 |
| Monthly Grams of Heroin Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | September 2023 | 0 | 53 |
| Monthly Grams of Fentanyl Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | September 2023 | 399 | 3,733 |
| Monthly Grams of Cocaine Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | September 2023 | 256 | 20,699 |
| Monthly Grams of Cocaine Based Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | September 2023 | 62 | 1,015 |
| Monthly Grams of Methamphetamine Seized by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | September 2023 | 907 | 2,589 |
| Drug Arrests for Heroin by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 53 | 53 |
| Drug Arrests for Cocaine by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 122 | 122 |
| Drug Arrests for Fentanyl by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 229 | 229 |
| Drug Arrests for Methamphetamine by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 81 | 81 |
| Drug Arrests for Substances other than Heroin, Fentanyl, Cocaine, and Methamphetamine by MDEA | Interdiction | Public Safety | 13.a; 13.b | Annually | 2022 | 0 | 0 |
| Monthly Drug Arrests for Heroin by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | August 2023 | 1 | 3 |
| Monthly Drug Arrests for Cocaine by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | August 2023 | 12 | 38 |
| Monthly Drug Arrests for Fentanyl by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | August 2023 | 11 | 67 |
| Monthly Drug Arrests for Methamphetamine by MDEA | Interdiction | Public Safety | 13.a; 13.b | Monthly | August 2023 | 4 | 23 |
| Total Monthly Drug Arrests in Maine | Interdiction | Public Safety | 13.a, 13.b.; 13.c | Monthly | March 2023 | 1,182 | 3,071 |
| Monthly Drug Arrests in Maine for Pharmaceutical Opioids | Interdiction | Public Safety | 13.a, 13.b.; 13.c | Monthly | March 2023 | 8 | 16 |
| Monthly Drug Arrests in Maine for Methamphetamine | Interdiction | Public Safety | 13.a, 13.b.; 13.c | Monthly | March 2023 | 114 | 301 |
| Monthly Drug Arrests in Maine for Fentanyl | Interdiction | Public Safety | 13.a, 13.b.; 13.c | Monthly | March 2023 | 35 | 75 |
| Monthly Drug Arrests in Maine for Heroin | Interdiction | Public Safety | 13.a, 13.b.; 13.c | Monthly | March 2023 | 114 | 321 |
| Monthly Drug Arrests in Maine for Cocaine | Interdiction | Public Safety | 13.a, 13.b.; 13.c | Monthly | March 2023 | 42 | 125 |
| Admissions to the MDOC for new primary sentence for a drug crime | Corrections | Public Safety | 13.b. | Annually | 2022 | 181 | 181 |
| Admissions to the MDOC for new primary sentence for a drug crime for men | Corrections | Public Safety | 13.b. | Annually | 2022 | 139 | 139 |
| Admissions to the MDOC for new primary sentence for a drug crime for women | Corrections | Public Safety | 13.b. | Annually | 2022 | 42 | 42 |
| Percent of Exits from Custody to Reunification/a> | Adverse Childhood Experiences | Prevention | 8 | Annually | 2022 | 58% | 58% |
| Rate of Substance Use as a Risk Factor at Removal of Child/a> | Adverse Childhood Experiences | Prevention | 8 | Annually | 2019 | 50% | 50% |
| Pro-active referrals made to OPTIONS teams | OPTIONS | Prevention | 8.d. | Monthly | January 2024 | 360 | 360 |
| Number of Individuals Admitted to Maine Adult Drug Treatment Courts | Judiciary | Prevention | 8.d. | Quarterly | Q4 2021 | 50 | 128 |
| Number of Individuals Graduated from Maine Adult Drug Treatment Courts | Judiciary | Prevention | 8.d. | Quarterly | Q4 2021 | 12 | 49 |
| Number of Individuals Involuntarily Terminated from Maine Adult Drug Treatment Courts | Judiciary | Prevention | 8.d. | Quarterly | Q4 2021 | 22 | 50 |
| Suspected Emergency Department Drug Overdose | Overdose | Harm Reduction | 20.b. | Quarterly | Q4 2023 | 931 | 4,004 |
| Deduplicated minimum monthly number of nonfatal overdoses | Overdose | Harm Reduction | Priority E | Monthly | January 2024 | 629 | 629 |
| Monthly EMS Incidents Requiring Naloxone Administration | Overdose | Harm Reduction | Priority E | Monthly | December 2023 | 95 | 1,544 |
| Annual Number of EMS Incidents Requiring Naloxone Administration | Overdose | Harm Reduction | Priority E | Annually | 2023 | 1,544 | 1,544 |
| Monthly EMS Incidents for Overdose Response | Overdose | Harm Reduction | Priority E | Monthly | December 2023 | 1,035 | 9,332 |
| Number of Trainings Conducted by OPTIONS Teams | OPTIONS | Harm Reduction | 20.a; 20.b.; 20.c. | Monthly | January 2024 | 16 | 16 |
| Number of People Trained by OPTIONS Teams | OPTIONS | Harm Reduction | 20.a; 20.b.; 20.c. | Monthly | January 2024 | 211 | 211 |
| Number of Community Events Staffed by OPTIONS Teams | OPTIONS | Harm Reduction | 20.a; 20.b.; 20.c. | Monthly | January 2024 | 27 | 27 |
| Number of Syringes Distributed at SSP Programs | SSP | Harm Reduction | 20.d. | Annually | 2022 | 2,368,746 | 2,368,746 |
| Number of Syringes Collected at SSP Programs | SSP | Harm Reduction | 20.d. | Annually | 2022 | 2,425,814 | 2,425,814 |
| Total Number of Syringes Distributed and Collected at SSP Programs | SSP | Harm Reduction | 20.d. | Annually | 2022 | 4,794,560 | 4,794,560 |
| Number of Syringe Exchanges at SSP Programs | SSP | Harm Reduction | 20.d. | Annually | 2022 | 20,047 | 20,047 |
| Total Enrollees in SSP Programs | SSP | Harm Reduction | 20.d. | Annually | 2022 | 6,719 | 6,719 |
| New Enrollees in SSP Programs | SSP | Harm Reduction | 20.d. | Annually | 2022 | 1,677 | 1,677 |
| Referrrals to Services and Medical Care by SSPs for Clients | SSP | Harm Reduction | 20.d. | Annually | 2022 | 7,810 | 7,810 |
| Naloxone Doses Distributed to ME EMS for the Leave Behind Program | Naloxone | Harm Reduction | 20.h. | Monthly | January 2024 | 352 | 352 |
| Naloxone Doses Distributed by ME EMS to Patients | Naloxone | Harm Reduction | 20.h. | Monthly | January 2024 | 42 | 42 |
| Naloxone Doses Distributed by the Maine Naloxone Distribution Initiative | Naloxone | Harm Reduction | 21.a. | Monthly | January 2024 | 10,686 | 10,686 |
| Reported Number of Opioid Overdose Reversals Using State Supplied Naloxone | Naloxone | Harm Reduction | 21.a. | Monthly | January 2024 | 139 | 139 |
| Number of Doses of Naloxone Distributed by OPTIONS Teams | OPTIONS | Harm Reduction | 21.a. | Monthly | January 2024 | 352 | 352 |
| Number of OPTIONS Clients Identified as Stably Housed | OPTIONS | Harm Reduction | 22.a. | Monthly | January 2024 | 271 | 271 |
| Number of OPTIONS Clients Identified as Unstably Housed | OPTIONS | Harm Reduction | 22.a. | Monthly | January 2024 | 138 | 138 |
| Number of OPTIONS Clients Identified as Unhoused | OPTIONS | Harm Reduction | 22.a. | Monthly | January 2024 | 166 | 166 |
| Percentage of Mainers Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.64% | 8.64% |
| Percentage of Mainers in Aroostook Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 7.53% | 7.53% |
| Percentage of Mainers in Central Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.22% | 8.22% |
| Percentage of Mainers in Cumberland Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.71% | 8.71% |
| Percentage of Mainers in Downeast Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.08% | 8.08% |
| Percentage of Mainers in Midcoast Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.43% | 8.43% |
| Percentage of Mainers in Penquis Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.39% | 8.39% |
| Percentage of Mainers in Western Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 9.79% | 9.79% |
| Percentage of Mainers in York Health District Estimated to Have Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.82% | 8.82% |
| Number of MaineCare Claims for Alcohol Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 2,805 | 2,805 |
| Number of MaineCare Claims for Amphetamines Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 0 | 0 |
| Number of MaineCare Claims for Cannabis Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 488 | 488 |
| Number of MaineCare Claims for Cocaine Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 412 | 412 |
| Number of MaineCare Claims for Drug-Induced Mental Disorders | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 0 | 0 |
| Number of MaineCare Claims for Hallucinogens Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 9 | 9 |
| Number of MaineCare Claims for Inhalants Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 0 | 0 |
| Number of MaineCare Claims for Nicotine Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 21 | 21 |
| Number of MaineCare Claims for Opioids Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 15704 | 15704 |
| Number of MaineCare Claims for Unspecified Substance Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 0 | 0 |
| Number of MaineCare Claims for Non-Cocaine, Non-Amphetmine Stimulant Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 348 | 348 |
| Number of MaineCare Claims for Multiple Psychoactive SubstanceTreatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 206 | 206 |
| Number of MaineCare Claims for Sedatives/Barbituates Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 68 | 68 |
| Number of MaineCare Claims for Substance-Use Disorder Treatment | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 22,080 | 22,080 |
| Percentage of Mainers Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.04% | 8.04% |
| Percentage of Mainers in Aroostook Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 6.98% | 6.98% |
| Percentage of Mainers in Central Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 7.83% | 7.83% |
| Percentage of Mainers in Cumberland Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.30% | 8.30% |
| Percentage of Mainers in Downeast Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 7.35% | 7.35% |
| Percentage of Mainers in Midcoast Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 7.76% | 7.76% |
| Percentage of Mainers in Penquis Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.04% | 8.04% |
| Percentage of Mainers in Western Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.78% | 8.78% |
| Percentage of Mainers in York Health District Estimated to Have Untreated Substance Use Disorder | Prevalence | Treatment | Priority F; G. | Annually | 2019 | 8.02% | 8.02% |
| Number of Referrals to MaineMOM by OPTIONS teams | OPTIONS | Treatment | 23.a. | Monthly | January 2024 | 1 | 1 |
| Number of Babies Born Substance Exposed/Affected | Prevalence | Treatment | 23.d; 23. e.; 23.j; 23.k; 23.l. | Annually | 2023 | 635 | 635 |
| Number of Buprenorphine Prescriptions | MOUD | Treatment | 24 | Monthly | April 2023 | 24,844 | n/a |
| Number of Buprenorphine Patients Receiving at Least One Prescription | MOUD | Treatment | 24 | Monthly | December 2022 | 14,183 | n/a |
| Monthly Census of Patients Provided Buprenorphine through Opioid Treatment Programs | MOUD | Treatment | 24 | Monthly | September 2023 | 196 | n/a |
| Monthly Census of Patients Receiving Methadone Treatment | MOUD | Treatment | 24 | Monthly | September 2023 | 4,888 | n/a |
| Clients Receiving Referrals to Rapid Induction at the ED by OPTIONS Teams | OPTIONS | Treatment | 24.a. | Monthly | January 2024 | 3 | 3 |
| Maine Department of Corrections Residents Enrolled in SUD Services | Corrections | Treatment | 24.b. | Annually | 2022 | 768 | 768 |
| Maine Department of Corrections Residents Transitioned to Community SUD Services | Corrections | Treatment | 24.b. | Annually | 2022 | 468 | 468 |
| Maine Department of Corrections Residents Receiving MOUD | Corrections | Treatment | 24.b. | Annually | 2022 | 468 | 468 |
| Maine Department of Corrections Male Residents Receiving MOUD | Corrections | Treatment | 24.b. | Annually | 2022 | 408 | 408 |
| Maine Department of Corrections Female Residents Receiving MOUD | Corrections | Treatment | 24.b. | Annually | 2022 | 60 | 60 |
| Maine Department of Corrections Residents Who Completed SUD Programming | Corrections | Treatment | Priority G | Annually | 2022 | 478 | 478 |
| Maine Department of Corrections Male Residents Who Completed SUD Programming | Corrections | Treatment | Priority G | Annually | 2022 | 395 | 395 |
| Maine Department of Corrections Female Residents Who Completed SUD Programming | Corrections | Treatment | Priority G | Annually | 2022 | 83 | 83 |
| Referrals Made for Clients to SUD Treatment Programs by OPTIONS Teams | OPTIONS | Treatment | Priority G | Monthly | January 2024 | 175 | 175 |
| Total Number of Recovery Community Centers | Community | Recovery | Strategy 29.a. | Annually | 2023 | 17 | 17 |
| Number of Individuals Admitted to Maine Adult Drug Treatment Courts | Judiciary | Recovery | Strategy 30.a; 30.b | Quarterly | Q4 2021 | 50 | 128 |
| Number of Individuals Graduated from Maine Adult Drug Treatment Courts | Judiciary | Recovery | Strategy 30.a; 30.b | Quarterly | Q4 2021 | 12 | 49 |
| Number of Individuals Involuntarily Terminated from Maine Adult Drug Treatment Courts | Judiciary | Recovery | Strategy 30.a; 30.b | Quarterly | Q4 2021 | 22 | 50 |
| Referrals to Community Based Recovery Supports by OPTIONS Teams | OPTIONS | Recovery | Priority H | Monthly | January 2024 | 170 | 170 |